Esophageal Cancer Clinical Trials

A listing of Esophageal Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Research Center
Additional Locations Alabama

A Randomised Phase III Double-Blind Placebo-Controlled Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)

View More ▼

Birmingham Alabama 35294

A clinical trial to evaluate treatments using INCB062079 for patients

Alaska

Research Center
Additional Locations Alaska

A Randomised Phase III Double-Blind Placebo-Controlled Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)

Arizona

Research Center
Additional Locations Arizona

A Randomised Phase III Double-Blind Placebo-Controlled Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)

Arkansas

Research Center
Additional Locations Arkansas

A Randomised Phase III Double-Blind Placebo-Controlled Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)

California

Research Center
Additional Locations California

A Randomised Phase III Double-Blind Placebo-Controlled Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)

View More ▼

Los Angeles California 90033

A clinical trial seeking patients for a research study for the treatment of Esophageal Cancer or Gastric Cancer

Los Angeles California 90095

A clinical trial seeking patients for a research study for the treatment of Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma or Esophageal Adenocarcinoma

UPDATED

San Francisco California 94143

Patients are needed to participate in a clinical research study to evaluate Esophageal Cancer or GastroEsophageal Cancer

Colorado

Research Center
Additional Locations Colorado

A Randomised Phase III Double-Blind Placebo-Controlled Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)

View More ▼

Aurora Colorado 80045

A clinical trial seeking patients for a research study for the treatment of Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma or Esophageal Adenocarcinoma

Aurora Colorado 080045

Patients are needed to participate in a clinical research study of IMMU-132

Connecticut

Research Center
Additional Locations Connecticut

A Randomised Phase III Double-Blind Placebo-Controlled Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)

View More ▼

New Haven Connecticut 06520

A clinical trial seeking patients for a research study for the treatment of Gastric Cancer, Stomach Cancer or Esophageal Cancer

New Haven Connecticut 06511

Patients are needed to participate in a clinical research study of IMMU-132

Delaware

Research Center
Additional Locations Delaware

A Randomised Phase III Double-Blind Placebo-Controlled Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)

View More ▼

Newark Delaware 19713

Patients are needed to participate in a clinical research study of IMMU-132

District of Columbia

Washington District of Columbia 20007

A clinical trial seeking patients for a research study for the treatment of Gastric Cancer, Stomach Cancer or Esophageal Cancer

Florida

Research Center
Additional Locations Florida

A Randomised Phase III Double-Blind Placebo-Controlled Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)

View More ▼

Orlando Florida 32806

Patients are needed to participate in a clinical research study of IMMU-132

Tampa Florida 33612

Patients are needed to participate in a clinical research study of IMMU-132

Georgia

Research Center
Additional Locations Georgia

A Randomised Phase III Double-Blind Placebo-Controlled Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)

Hawaii

Research Center
Additional Locations Hawaii

A Randomised Phase III Double-Blind Placebo-Controlled Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)

Idaho

Research Center
Additional Locations Idaho

A Randomised Phase III Double-Blind Placebo-Controlled Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)

Illinois

Research Center
Additional Locations Illinois

A Randomised Phase III Double-Blind Placebo-Controlled Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)

View More ▼

Chicago Illinois 60637

A clinical trial seeking patients for a research study for the treatment of Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma or Esophageal Adenocarcinoma

Chicago Illinois 60637

A clinical trial seeking patients for a research study for the treatment of Gastric Cancer, Stomach Cancer or Esophageal Cancer

Chicago Illinois 60612

Patients are needed to participate in a clinical research study of Durvalumab to evaluate Esophageal Cancer

Indiana

Research Center
Additional Locations Indiana

A Randomised Phase III Double-Blind Placebo-Controlled Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)

View More ▼

Goshen Indiana 46526

Patients are needed to participate in a clinical research study of IMMU-132

Indianapolis Indiana 46202

Patients are needed to participate in a clinical research study of Durvalumab to evaluate Esophageal Cancer

Iowa

Research Center
Additional Locations Iowa

A Randomised Phase III Double-Blind Placebo-Controlled Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)

View More ▼

Iowa City Iowa 52242

Patients are needed to participate in a clinical research study of Durvalumab to evaluate Esophageal Cancer

Kansas

Research Center
Additional Locations Kansas

A Randomised Phase III Double-Blind Placebo-Controlled Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)

Kentucky

Research Center
Additional Locations Kentucky

A Randomised Phase III Double-Blind Placebo-Controlled Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)

Louisiana

Research Center
Additional Locations Louisiana

A Randomised Phase III Double-Blind Placebo-Controlled Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)

Maine

Research Center
Additional Locations Maine

A Randomised Phase III Double-Blind Placebo-Controlled Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)

Maryland

Research Center
Additional Locations Maryland

A Randomised Phase III Double-Blind Placebo-Controlled Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)

View More ▼

Baltimore Maryland 21287

A clinical trial seeking patients for a research study for the treatment of Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma or Esophageal Adenocarcinoma

Baltimore Maryland 21287

A clinical trial seeking patients for a research study for the treatment of Gastric Cancer, Esophageal Cancer or GastroEsophageal Cancer

Baltimore Maryland 21231

A clinical trial seeking patients for a research study for the treatment of Gastric Cancer, Stomach Cancer or Esophageal Cancer

Massachusetts

Research Center
Additional Locations Massachusetts

A Randomised Phase III Double-Blind Placebo-Controlled Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)

View More ▼

Boston Massachusetts 02114

A clinical trial seeking patients for a research study for the treatment of Colorectal Cancer, Pancreatic Cancer or Esophageal Cancer

Boston Massachusetts 02215

A clinical trial seeking patients for a research study for the treatment of Gastric Cancer, Stomach Cancer or Esophageal Cancer

Boston Massachusetts 02114

Patients are needed to participate in a clinical research study of IMMU-132

Michigan

Research Center
Additional Locations Michigan

A Randomised Phase III Double-Blind Placebo-Controlled Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)

View More ▼

Ann Arbor Michigan 48109

Patients are needed to participate in a clinical research study of Durvalumab to evaluate Esophageal Cancer

Detroit Michigan 48201

A clinical study for patients with Breast Cancer, Lung Cancer or Pancreatic Cancer

Detroit Michigan 48201

A clinical trial seeking patients for a research study for the treatment of Gastric Cancer, Stomach Cancer or Esophageal Cancer

Detroit Michigan 48201

Patients are needed to participate in a clinical research study evaluating INO-1400 and INO-9012